glp 1 2025 Q&A: Long-term success of GLP-1 therapies hinges on more than just a prescription Obesity GLP-1 Market

Why is there so little research on GLP-1s and breastfeeding There are real ethical limits to studying medications in breastfeeding parents

The challenge is that stopping suddenly can make hunger, fullness, and digestion shift faster than expected

Pemp, Berthold (Department of Ophthalmology, Medical University of Vienna)

You need branded GLP-1s or insurance coverage

The 44% reduction in all-cause mortality observed among patients with obesity and co-occurring autoimmune disease is a striking finding that demands our attention, said Fatima Cody Stanford, MD, associate professor of medicine and pediatrics at Harvard Medical School, who was not involved in the study

We advocate for a holistic view of health